Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • ASCI Milestone Awards
    • Video Abstracts
    • Conversations with Giants in Medicine
  • Reviews
    • View all reviews ...
    • The cGAS-STING pathway: DNA sensing in health and disease (Jun 2026)
    • Neurodegeneration (Mar 2026)
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • ASCI Milestone Awards
  • Video Abstracts
  • Conversations with Giants in Medicine
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Long noncoding RNA LERFS negatively regulates rheumatoid synovial aggression and proliferation
Yaoyao Zou, Siqi Xu, Youjun Xiao, Qian Qiu, Maohua Shi, Jingnan Wang, Liuqin Liang, Zhongping Zhan, Xiuyan Yang, Nancy Olsen, Song Guo Zheng, Hanshi Xu
Yaoyao Zou, Siqi Xu, Youjun Xiao, Qian Qiu, Maohua Shi, Jingnan Wang, Liuqin Liang, Zhongping Zhan, Xiuyan Yang, Nancy Olsen, Song Guo Zheng, Hanshi Xu
View: Text | PDF
Research Article Immunology

Long noncoding RNA LERFS negatively regulates rheumatoid synovial aggression and proliferation

  • Text
  • PDF
Abstract

Fibroblast-like synoviocytes (FLSs) are critical to synovial aggression and joint destruction in rheumatoid arthritis (RA). The role of long noncoding RNAs (lncRNAs) in RA is largely unknown. Here, we identified a lncRNA, LERFS (lowly expressed in rheumatoid fibroblast-like synoviocytes), that negatively regulates the migration, invasion, and proliferation of FLSs through interaction with heterogeneous nuclear ribonucleoprotein Q (hnRNP Q). Under healthy conditions, by binding to the mRNA of RhoA, Rac1, and CDC42 — the small GTPase proteins that control the motility and proliferation of FLSs — the LERFS–hnRNP Q complex decreased the stability or translation of target mRNAs and downregulated their protein levels. But in RA FLSs, decreased LERFS levels induced a reduction of the LERFS–hnRNP Q complex, which reduced the binding of hnRNP Q to target mRNA and therefore increased the stability or translation of target mRNA. These findings suggest that a decrease in synovial LERFS may contribute to synovial aggression and joint destruction in RA and that targeting the lncRNA LERFS may have therapeutic potential in patients with RA.

Authors

Yaoyao Zou, Siqi Xu, Youjun Xiao, Qian Qiu, Maohua Shi, Jingnan Wang, Liuqin Liang, Zhongping Zhan, Xiuyan Yang, Nancy Olsen, Song Guo Zheng, Hanshi Xu

×

Figure 3

Effect of LERFS overexpression on the proliferation and apoptosis of RA FLSs.

Options: View larger image (or click on image) Download as PowerPoint
Effect of LERFS overexpression on the proliferation and apoptosis of RA ...
(A and B) An EdU incorporation assay was performed to evaluate cell proliferation. Representative images show proliferation of RA FLSs (A) and HC FLSs (C) labeled with EdU (red) and nuclei stained with Hoechst 33342 (blue) (original magnification, ×200). Graphs in A and C indicate the mean ± SEM of 5 independent experiments involving 5 different RA patients or HCs. (B) Detection of cell growth rates in vitro using an MTT assay at the indicated time points after lentivirus infection (D0 indicates the day of infection). Values are expressed relative to D0 as the mean ± SEM of 5 independent experiments. (D and E) Effects of LERFS overexpression on phases of the cell cycle. (D) Representative plots of cell-cycle distribution. (F) LERFS knockdown promotes proliferation by HC FLSs. Representative images are shown (original magnification, ×200). Data are shown as the mean ± SEM of 5 independent experiments involving 5 different RA patients (E) or HCs (F). (G) Effect of LERFS overexpression on apoptosis of RA FLSs. The cellular apoptosis rate was measured by annexin V and 7-AAD staining and detected by flow cytometry. Representative flow plots are shown. Total apoptosis represents the mean ± SEM percentage of 5 independent experiments involving 5 different RA patients. (H) Quantitative measurement of caspase 3/7 activity. Data are expressed relative to vector values and presented as the mean ± SEM of 5 independent experiments involving 5 different RA patients. (I) Effect of LERFS overexpression on FasL-induced apoptosis of RA FLSs. Cells were stimulated with or without 100 ng/ml recombinant human FasL for 24 hours. Total apoptosis represents the mean ± SEM of 3 independent experiments involving 3 different RA patients. *P < 0.05, **P < 0.01, and ***P < 0.001 versus vector, by Student’s t test.

Copyright © 2026 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts